The Scientific and Technical Council of the Center recommends:
- for re-registration of medicinal products – 22;
- for re-registration of substances – 1;
- for registration of substances – 5;
- amendments to registration materials for medicinal products – 264 (including 4 medicinal products for the treatment of Covid-19);
- amendments to protocols of international multicenter clinical trials of medicinal products – 35 (including 3 medicinal products for the treatment of Covid-19).
The Scientific Expert Council of the Center recommends:
- for registration of medicinal products – 26;
- for approval of international multicenter clinical trials – 16;
- to approval of the start of clinical trials of medicinal products of domestic manufacturers – 2;
- before approval of protocols of international multicenter clinical trials – 2 (Covid-19).
